Analysis Of Plasma Kim-1 As A Biomarker For Recurrence Risk After Resection For Localized Renal Cell Carcinoma.

JOURNAL OF CLINICAL ONCOLOGY(2021)

引用 0|浏览12
暂无评分
摘要
342Background: Recurrence is common after nephrectomy for renal cell carcinoma (RCC), but no circulating biomarkers are available to identify patients at highest risk of recurrence who may benefit ...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要